Pharmaceutical Technology

APRIL 27, 2023

The European Commission is expected to make an early decision on Columvi’s authorisation. The CHMP’s recommendation for Columvi brings us closer to providing a new, fixed-duration therapy for people with diffuse large B-cell lymphoma that induces early and long-lasting responses.”

Medicine 52

Medicine Safety Patients Leads 52

Pharmaceutical Technology

APRIL 5, 2023

The therapy is currently under development for the treatment of patients with relapsed or refractory multiple myeloma (r/r MM). Caribou is presently conducting its Phase l CaMMouflage trial to assess CB-011 in r/r MM patients. The newly granted designation helps the firm accelerate the development and evaluation of CB-011.

Food and Drug Administration 59

Food and Drug Administration FDA Manufacturing Food 59

European Pharmaceutical Review

JANUARY 31, 2023

It is the “… first and only targeted treatment option clinically proven to reduce both oesophageal inflammation and damage,” explained Dr Naimish Patel, Head of Global Development, Immunology and Inflammation at Sanofi. Improvements were observed as early as four weeks.

Medicine 84

Medicine Safety Patients Pharmaceutical 84

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. Personalised medicines will also be developed at the centre. Personalised medicines will also be developed at the centre.

Manufacturing 105

Manufacturing Distribution Medicine Patients 105

PM360

APRIL 22, 2024

Making the Case for Early Medical Affairs Involvement Early involvement of Medical Affairs in the product lifecycle is not just beneficial—it is mission critical. A clear understanding of the steps highlighted below will help the development of strong scientific partnership-based engagements with stakeholders.

Medical 52

Medical Healthcare Healthcare Education 52

Pharmaceutical Technology

MAY 24, 2023

The RMAT designation programme is intended to accelerate the drug’s development and review processes for products, including gene therapies. It also provides the ability for early FDA interactions, support accelerated approvals and priority review of biologics licensing applications.

Pharmaceutical 52

Pharmaceutical Food and Drug Administration FDA Food 52

pharmaphorum

NOVEMBER 11, 2022

The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. While the data for 2021 isn’t complete, early signs are that it has fallen further to 6%.

Recruitment 78

Recruitment Pharma Education FDA 78

Pharmaceutical Technology

SEPTEMBER 22, 2022

According to initial findings from the Phase I/II clinical trial, which is underway at the University of California San Diego, the therapy was found to be well tolerated. The FDA's rare pediatric disease designation and Voucher Program aid the development of new drugs and biologics to prevent and treat rare paediatric ailments. .

Food and Drug Administration 59

Food and Drug Administration FDA Food Pharmaceutical 59

Pharmaceutical Technology

AUGUST 30, 2022

The approval is based on findings from the Phase II/III clinical trial of the mRNA-1273.214 vaccine. The company is collaborating with Swissmedic and the Government of Switzerland to supply the mRNA-1273.214 vaccine to people in the country by early September this year. According to the study data, the trial met all primary endpoints.

Government 52

Government Safety Pharmaceutical Medicine 52

Pharmaceutical Technology

MAY 17, 2023

Both platforms use the company’s development, manufacturing and analytical capabilities in lentiviral vector (LVV) and adeno-associated viral vector (AAV). AGC Biologics’ proprietary procedure and capsid-based platform methods can speed up development timelines, thereby enabling the delivery of GMP products in nine months.

Manufacturing 52

Manufacturing Networking Patients Leads 52

Pharmaceutical Technology

MAY 24, 2023

Our board and management team believe that the combined company will be well-positioned to develop powerful new therapies with the potential to overcome resistance to current immunotherapies, an area of significant unmet need.” Topic sponsors are not involved in the creation of editorial content.

Leads 52

Leads Patients Management Pharmaceutical 52

pharmaphorum

NOVEMBER 25, 2022

German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan’s Kyowa Kirin, which are currently sold by affiliate companies across Europe.

Medicine 52

Medicine Marketing Pharma Management 52

Clarivate

MAY 26, 2022

Drug and device makers face daunting odds in seeking to bring a product from Phase I clinical trials through to market approval – according to the Massachusetts Institute of Technology’s Project Alpha, a mere 10.5% Engaging regulators early and often. Engaging regulators early and often. make it to market. [1]. References. [1]

Marketing 52

Marketing Patients Recruitment Management 52

Pharmaceutical Technology

NOVEMBER 29, 2022

On November 14, the Canadian developer PharmaTher announced positive data from a Phase I/II study where ketamine was used to treat levodopa-induced dyskinesia in Parkinson’s disease. The company now plans to move this approach into a Phase III trial. In 1970, the FDA approved ketamine as an anesthetic.

Side effects 110

Side effects Pharmaceutical Patients Medicine 110

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said.

Patients 96

Patients Pharmaceutical Medical Physicians 96

pharmaphorum

NOVEMBER 16, 2022

Having presented the data from the 24-month phase 3 trial at the American Academy of Ophthalmology (AAO) annual meeting, Dr Wykoff set aside some time to go into further detail with pharmaphorum about how the results were received, and what glimmer of hope this might hold for patients with GA. “As That’s the efficacy data.

Safety 98

Safety Patients Consulting Prospecting 98

pharmaphorum

JANUARY 19, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. Pretty much every system in the developed world is a late-stage sick system and failing. he exclaimed.

Pharma 75

Pharma Competition Healthcare Healthcare 75

Celeritas

MARCH 3, 2023

Data Analytics is the next phase in the evolutionary data cycle. Getting quick, detailed, and accurate reports on animal health related topics a game-changer. Dr. Ed Tucker, VP of Janssen Research & Development put it best in an interview with MIT Sloan Management Review.

Food 98

Food Training Prescription Management 98

Pharmaceutical Technology

JUNE 15, 2023

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. Once the target is identified, researchers work to develop a compound that can interact with it.

Food and Drug Administration 52

Food and Drug Administration Side effects Recruitment Safety 52

Impetus Digital

JANUARY 13, 2023

As a result, they will see higher-quality insights and be able to develop a clear plan for how to leverage these. In particular, AI-enabled sentiment analysis was a hot topic in 2022, but this will not replace manual analyses by medical writers and other human experts. Improved patient-centricity goes hand-in-hand with DEI initiatives.

Pharma 94

Pharma Medical Patients Healthcare 94

European Pharmaceutical Review

JANUARY 29, 2024

17 Accelerating drug development The first issue of 2023 , 18 dealt with accelerating drug development. Repurposing of currently marketed products, eg, methotrexate, 20 was an important and effective strategy in combatting COVID-19, particularly in the early stages prior to effective vaccines being developed.

Pharmaceutical 94

Pharmaceutical Food and Drug Administration Medicine FDA 94

Integrity Solutions

MAY 13, 2021

Maximizing talent, developing a customer-centric culture and achieving aggressive sales goals are all made possible through ethical, values-driven behaviors. Let’s take a look at these selling principles and underlying beliefs that enable salespeople to build trust and develop valuable, lasting relationships with customers.

Ethics 87

Ethics Sales Sales process B2B Sales 87

PM360

SEPTEMBER 15, 2022

To work directly with patients to develop medications, service offerings, information toolkits, and anything else that could address their unmet needs. The increased relevance and usage of social media is significant and is likely to be integral in gathering insights to inform the drug development pathway. Lisa Lishman. Jen Horonjeff.

Patients 98

Patients Healthcare Healthcare Marketing 98

Pharmaceutical Technology

FEBRUARY 8, 2023

In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases. This document delved into aspects related to manufacturing, preclinical, and clinical trial design for all phases of clinical development.

FDA 105

FDA Pharmacology Patients Pharmaceutical 105

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Another major topic covered by the experts was technological advances. Miriam Guest, Principal Microbiologist at AstraZeneca.

Pharmaceutical 125

Pharmaceutical Food and Drug Administration Manufacturing FDA 125

Pharmaceutical Technology

APRIL 6, 2023

The PRIME scheme designation was granted by the EMA based on positive results obtained from the ongoing Phase IIb randomised, open-label KEYNOTE-942/mRNA-4157-P201 trial that enrolled 157 patients with stage III/IV melanoma. Topic sponsors are not involved in the creation of editorial content.

Medicine 98

Medicine Patients Leads Medical 98

Medico Reach

OCTOBER 17, 2022

Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. Development Of New Biotech Coating In Orthopedic Medical Devices. One of the most exciting orthopedic medical device trends is the development of new bioactive coatings and composites for bone implants.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

Rep-Lite

JANUARY 25, 2024

The shift towards hospital-based treatments, as opposed to home care, gained traction in the late 1800s and early 1900s due to advancements in sanitation and the introduction of antiseptics. Early Days (Pre-1970s): Healthcare institutions traditionally handled recruitment internally, relying on personal networks and basic advertising methods.

Recruitment 52

Recruitment Specialization Healthcare Healthcare 52

Medico Reach

OCTOBER 17, 2022

Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. Development Of New Biotech Coating In Orthopedic Medical Devices. One of the most exciting orthopedic medical device trends is the development of new bioactive coatings and composites for bone implants.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

pharmaphorum

JANUARY 23, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. We have the most unbelievable, exponential developments taking place. It is about money.

Pharma 83

Pharma Food Pharmacology Medicine 83

Evolve Your Success

JULY 12, 2022

He runs an organization that helps medical sales reps grow in their careers and develop a brand through social media, as we hear it evolve as success. We’re going to cover these three topics. We’re going to cover those three topics, but then we’re also going to do a little bit of fireside Q&A.

Medical sales reps 52

Medical sales reps Medical sales Media Sales 52

Pharma Marketing Network

JANUARY 20, 2021

In other areas of the industry (such as cell and genetic medicine development) progress continued at an impressively brisk pace despite the pandemic. Here, we provide some insights on 3 key topics based on panel discussions with industry leaders at this year’s event. #1.

Healthcare 52

Healthcare Healthcare Medicine Patients 52

Pharma Marketing Network

OCTOBER 27, 2020

She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. As a speaker Robin has had over a hundred and forty speaking engagements in 13 countries and she’s the author of two books, The Patient as CEO and Thought Leader Formula.

Education 52

Education Marketing Healthcare Healthcare 52

Pharma Marketing Network

OCTOBER 27, 2020

She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. As a speaker Robin has had over a hundred and forty speaking engagements in 13 countries and she’s the author of two books, The Patient as CEO and Thought Leader Formula.

Education 52

Education Healthcare Healthcare Doctors 52

Salesforce

APRIL 27, 2021

With Work.com , our customers can create customized solutions to support their needs as they move through the phases of this crisis. As we begin to enter the second phase, the global dialogue around COVID-19 has shifted to reopening, how to get the economy going and how to do it safely. You can learn more about Work.com here.

Safety 52

Safety Government Healthcare Healthcare 52

Sales Talent

FEBRUARY 15, 2023

You can read our post, How to Prepare for a Sales Interview , to learn more on the topic. Early on, I knew I wanted to go to college, so I got a job at 14 and started saving. Early on, I realized that our offering was a great fit for them, but they were acquired right after that, and all new purchases were frozen.

Sales 59

Sales Prospecting Sales process Management 59

Pharma Marketing Network

NOVEMBER 4, 2020

I have with me today Tom Ollerton from Automated Creative which is doing some really fascinating things when it comes to applying artificial intelligence to the creative development process in measuring process. Welcome Tom. RJ (PMN): I’m glad you could make it. Tom (AC): We set out to reinvent advertising using AI.

Marketing 52

Marketing Pharma Media Networking 52